ATROPINE SULFATE IN and 9 more items
Open Solicitation Posted
- Solicitation number
- SPE2DP27T0231
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
Defense Logistics Agency Troop Support Medical seeks quotes for atropine sulfate injection under request for quotation SPE2DP27T0231, with quotes due November 9, 2026. The solicitation carries no set-aside.
The RFQ covers ten line items, each for ATROPINE SULFATE IN under NSN 6505-01-573-1657 (PSC 6505, Drugs and Biologicals), with quantities of 1 to 6 packages per line across separate purchase requests. Delivery is due within 5 days, FOB Destination with inspection and acceptance at destination. The government file summary places delivery at Fort Bragg, North Carolina. The solicitation is a Fast Auto Evaluation issued through DLA's Internet Bid Board System (DIBBS), which is the only permitted submission channel. Before award, the contracting official will refer the quotes to a product specialist for confirmation.
The file summary describes the product as atropine sulfate injection, USP, in 5 mL single-dose unit-of-use syringes with a male Luer lock adapter, at 0.1 mg/mL (0.5 mg per syringe). It identifies Pfizer Inc. (CAGE 86491, NDC 00409-4910-34) as the supplier. The material is FDA-regulated and requires hazardous material labeling, Medical Marking Standard No. 1, MIL-STD-129, and DLA packaging and quality standards. Technical and quality requirements RS016, RS001, RA001, RP001, RQ011, and RD003 apply. Berry Amendment domestic sourcing compliance is required. The solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions (Revision 5, May 20, 2026), along with FAR, DFARS, and DLAD provisions and clauses.
Notice text
DLA request for quotation SPE2DP27T0231, issued by DLA office SPE2DP through DIBBS. Quotes are due by 11/09/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Items: line 0001, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 6 PG, delivery in 5 days, PR 7018972940; line 0002, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 1 PG, delivery in 5 days, PR 7018972655; line 0003, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 2 PG, delivery in 5 days, PR 7018972943; line 0004, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 3 PG, delivery in 5 days, PR 7018972942; line 0005, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 3 PG, delivery in 5 days, PR 7018972656; line 0006, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 1 PG, delivery in 5 days, PR 7018972944; line 0007, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 1 PG, delivery in 5 days, PR 7018972658; line 0008, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 1 PG, delivery in 5 days, PR 7018972657; line 0009, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 6 PG, delivery in 5 days, PR 7018972659; line 0010, ATROPINE SULFATE IN, NSN 6505-01-573-1657, 2 PG, delivery in 5 days, PR 7018972941. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DP27T0231.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Atropine Auto-Injector | Medical Supply Chain | No set-aside | |
| APPLICATOR,SILVER NIT and 1 more item | Medical Supply Chain | No set-aside | |
| Bupivacaine and epine | Medical Supply Chain | No set-aside | |
| Sodium chloride injec | Medical Supply Chain | No set-aside | |
| Sodium chloride injec | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity